drug protocol number

1200.75

drug sponsor

Boehringer Ingelheim

drug study

BIBW 2992 / Vinorelbine / Trastuzumab

drug trial site

King Fahad Medical City (Riyadh), International Medical Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah)

drug status

Completed

drug phase